Rahul B Chavan
Overview
Explore the profile of Rahul B Chavan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
227
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chavan R, Lodagekar A, Yadav B, Shastri N
Drug Deliv Transl Res
. 2020 May;
10(4):903-918.
PMID: 32378174
The present study was designed to determine the applicability of a newly derived dimensionless number precipitation parameter, "supersaturation holding capacity (SHC)" in development of amorphous solid dispersion (ASD) of a...
2.
Chavan R, Rathi S, Jyothi V, Shastri N
Asian J Pharm Sci
. 2020 Feb;
14(3):248-264.
PMID: 32104456
Cellulose derivatives have gained immense popularity as stabilizers for amorphous solid dispersion owing to their diverse physicochemical properties. More than 20 amorphous solid dispersion-based products that have been approved for...
3.
Vikas A, Rashmin P, Mrunali P, Chavan R, Kaushik T
AAPS PharmSciTech
. 2020 Jan;
21(2):67.
PMID: 31938980
Onychomycosis is a chronic disorder that is difficult to manage and hard to eradicate with perilous trends to relapse. Due to increased prevalence of HIV, use of immunosuppressant drugs and...
4.
Lodagekar A, Chavan R, Mannava M, Yadav B, Chella N, Nangia A, et al.
Eur J Pharm Sci
. 2019 Aug;
139:105048.
PMID: 31446077
Co amorphous systems are supersaturated drug delivery systems which offer a basic platform for delivery of multicomponent adducts (combination of more than one active pharmaceutical ingredient (API)) and/or as a...
5.
Rathi S, Chavan R, Shastri N
Drug Deliv Transl Res
. 2019 Aug;
10(1):70-82.
PMID: 31407270
Supersaturated drug delivery systems are commonly used to address the problems of poor aqueous solubility posed by most of the active pharmaceutical ingredients (APIs). However, the supersaturated systems are highly...
6.
Bhavana V, Chavan R, Mannava M, Nangia A, Shastri N
Talanta
. 2019 Apr;
199:679-688.
PMID: 30952315
Niclosamide, an anthelmintic drug recently repurposed for its activity against cancer, crystallizes into three solvated forms, two monohydrates (NHa, NHb) and one anhydrous (NAn) form. NAn is sensitive to pseudopolymorphic...
7.
Lodagekar A, Borkar R, Thatikonda S, Chavan R, Naidu V, Shastri N, et al.
Carbohydr Polym
. 2019 Mar;
212:252-259.
PMID: 30832855
Niclosamide, previously used as an anthelmintic drug is currently being repurposed for its anticancer activity. Niclosamide is a brick like biopharmaceutical classification system (BCS) class II drug with poor aqueous...
8.
Chavan R, Lodagekar A, Shastri N
Drug Dev Ind Pharm
. 2018 Aug;
44(12):1933-1941.
PMID: 30102080
Objective: Present study was embarked with an objective to determine whether the polymers retain the same inhibitory potential after formulating them into ASDs. Methods: Screening of polymers was based on...
9.
Pardhi V, Chavan R, Thipparaboina R, Thatikonda S, Naidu V, Shastri N
Int J Pharm
. 2018 May;
544(1):304-306.
PMID: 29728271
No abstract available.
10.
Chavan R, Thipparaboina R, Yadav B, Shastri N
Drug Deliv Transl Res
. 2018 Jan;
8(6):1726-1739.
PMID: 29352367
The last decade has witnessed extensive growth in the field of co-crystallization for mitigating the solubility and dissolution-related issues of poorly soluble drugs. This is largely because co-crystals can modify...